Company: INDP
Filing Date: 2025-06-13
Form Type: PRE 14A
Source: 0001641172-25-014978
Chunk: 17

Company: Indaptus Therapeutics, Inc.
Filing Date: 2025-06-13
Form: PRE 14A
Chunk 17
---
 a copy of which is available upon
request to our Secretary. In the event that the date of the 2026 Annual Meeting is more than 30 days before or more than 60 days after
June 10, 2026, then our Secretary must receive such written notice not more than the 120th day prior to the 2026 Annual Meeting and not
later than the 90th day prior to the 2026 Annual Meeting or, if later, the 10th day following the day on which public disclosure of the
date of such meeting is first made by us.

To comply with the universal proxy rules, stockholders
who intend to solicit proxies in support of director nominees other than the Company’s nominees must provide notice that sets forth
the information required by Rule 14a-19 under the Exchange Act.

We reserve the right to reject, rule out of order,
or take other appropriate action with respect to any proposal that does not comply with these or other applicable requirements.

<div align='center'>10

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT</div>

The following table sets forth certain information
with respect to holdings of our common stock by (i) stockholders who beneficially owned more than 5% of the outstanding shares of our
common stock, and (ii) each of our directors (which includes all nominees), each of our named executive officers and all directors and
executive officers as a group as of June 12, 2025, unless otherwise indicated. The number of shares beneficially owned by each stockholder
is determined under rules issued by the SEC. Under these rules, beneficial ownership includes any shares as to which a person has sole
or shared voting power or investment power. Applicable percentage ownership is based on 16,034,444 shares of common stock outstanding
as of June 12, 2025. In computing the number of shares beneficially owned by a person and the percentage ownership of that person, shares
of common stock subject to options, or other rights held by such person that are currently exercisable or will become exercisable within
60 days of June 12 2025 are considered outstanding, although these shares are not considered outstanding for purposes of computing the
percentage ownership of any other person.

Unless otherwise indicated, the address of each
beneficial owner listed below is 3 Columbus Circle, 15 Floor, New York, NY 10019. We believe, based on information provided
to us